Juno Diagnostics: Juno Hazel Plus
JunoDx launched the Juno Hazel Plus non-invasive prenatal screening assay, along with an early access program. The lab-developed test screens for common chromosomal trisomies, sex chromosome aneuploidies, and fetal sex without the need for phlebotomy via JunoDx's proprietary fingerprick-based Sample Collection Kit. Juno Hazel Plus expands aneuploidy risk assessment beyond that offered by Juno Hazel. This includes screening for sex chromosome aneuploidies such as monosomy X (Turner syndrome), XXY syndrome (Klinefelter syndrome), triple X syndrome, and XYY syndrome (Jacobs syndrome), in addition to common aneuploidy screening and fetal sex testing. The early access program is meant to provide physicians, genetic counselors, and other providers with exclusive access to the company's suite of products and services in advance of public launch.